The Recall Desk
HighFDA (Drugs)·D-569-2014·Announced 2014-01-22

Aidapak Recalls GuaiFENesin ER Tablets Due to Label Mixup

Aidapak Services, LLC is recalling guaiFENesin ER tablets because they may be mislabeled as fenofibrate or glyburide. The error poses a risk of patients taking the wrong medication.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: The recall involves a label mixup where a patient could take the wrong medication (guaiFENesin vs. fenofibrate or glyburide). This is a risk-of-harm product where injury has not yet been reported, fitting the 'High' severity criteria.

Plain-English summary

Aidapak Services, LLC is voluntarily recalling guaiFENesin ER tablets, 600 mg, NDC 45802049878. The recall is due to a labeling error where the guaiFENesin tablets may be mislabeled as fenofibrate tablets, 54 mg, or glyburide tablets, 2.5 mg.

The affected repacked drugs were distributed in Arizona, California, Oregon, and Washington. The source text does not specify the total number of units recalled or report any illnesses or injuries associated with this labeling error.

Patients and healthcare providers should check their medication labels. If the label indicates fenofibrate or glyburide but the patient was prescribed guaiFENesin, they should contact their pharmacist or healthcare provider for guidance on the correct medication.

The recalled product

Product
guaiFENesin ER Tablet, 600 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 45802049878
Affected units
500

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (12)

  • guaiFENesin ER
  • Tablet
  • 600 mg has the following codes Pedigree: AD21790_58
  • EXP: 5/1/2014
  • Pedigree: W002734
  • EXP: 6/6/2014
  • Pedigree: W003689
  • EXP: 6/26/2014
  • Pedigree: AD30140_37
  • EXP: 5/7/2014
  • Pedigree: W003006
  • EXP: 6/11/2014.

Distribution

Distributed in 4 states:

Part of a larger recall action

This product is one of 273 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 273 products in this recall →

Same manufacturer · Aidapak Services, LLC

See all →